Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Haferkamp

Showing results (101-110 of 298) with videos related to

Pageof 30
Sort By:
Neoplasia (New York, N.Y.)|May 28, 2014
Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanismEva Juengel, Jasmina Makarević, Michael Reiter, et al.
The Journal of Urology|March 23, 2011
Selective transarterial embolization for posttraumatic renal hemorrhage: a second try is worthwhileJohannes Huber, Sascha Pahernik, Peter Hallscheidt, et al.
Cancer Letters|May 15, 2012
Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cellsEva Juengel, Anna Dauselt, Jasmina Makarević, et al.
Prostate Cancer and Prostatic Diseases|November 5, 2023
Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiencyMaximilian Haack, Nikita D Fischer, Lisa Frey, et al.
Journal of Cellular and Molecular Medicine|December 3, 2014
Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenibEva Juengel, Dana Kim, Jasmina Makarević, et al.
Discover Oncology|March 19, 2025
Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinomaMaximilian Haack, Stephanie Neuberger, Jan Hendrik Boerner, et al.
European Urology|October 12, 2004
Health-related quality-of-life following modified ureterosigmoidostomy (Mainz Pouch II) as continent urinary diversionPatrick J Bastian, Peter Albers, Herbert Hanitzsch, et al.
BJU International|December 17, 2008
Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantationNenad Djakovic, Nina Wagener, Judith Adams, et al.
Journal of Endourology|January 6, 2015
Introducing a Novel In Vitro Model to Characterize Hydrodynamic Effects of Percutaneous Nephrolithotomy SystemsRene Mager, Christopher Balzereit, Michael Reiter, et al.
European Urology Focus|June 27, 2018
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication RatesGeorg Salomon, Sandra Prues, Judith Saul, et al.
Pageof 30

Showing results (101-110 of 298) with videos related to

Sort By:
Pageof 30
Neoplasia (New York, N.Y.)|May 28, 2014
Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanismEva Juengel, Jasmina Makarević, Michael Reiter, et al.
The Journal of Urology|March 23, 2011
Selective transarterial embolization for posttraumatic renal hemorrhage: a second try is worthwhileJohannes Huber, Sascha Pahernik, Peter Hallscheidt, et al.
Cancer Letters|May 15, 2012
Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cellsEva Juengel, Anna Dauselt, Jasmina Makarević, et al.
Prostate Cancer and Prostatic Diseases|November 5, 2023
Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiencyMaximilian Haack, Nikita D Fischer, Lisa Frey, et al.
Journal of Cellular and Molecular Medicine|December 3, 2014
Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenibEva Juengel, Dana Kim, Jasmina Makarević, et al.
Discover Oncology|March 19, 2025
Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinomaMaximilian Haack, Stephanie Neuberger, Jan Hendrik Boerner, et al.
European Urology|October 12, 2004
Health-related quality-of-life following modified ureterosigmoidostomy (Mainz Pouch II) as continent urinary diversionPatrick J Bastian, Peter Albers, Herbert Hanitzsch, et al.
BJU International|December 17, 2008
Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantationNenad Djakovic, Nina Wagener, Judith Adams, et al.
Journal of Endourology|January 6, 2015
Introducing a Novel In Vitro Model to Characterize Hydrodynamic Effects of Percutaneous Nephrolithotomy SystemsRene Mager, Christopher Balzereit, Michael Reiter, et al.
European Urology Focus|June 27, 2018
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication RatesGeorg Salomon, Sandra Prues, Judith Saul, et al.
Pageof 30